The rise of immunotherapy topped all other advances in oncology during 2015, according to an annual research report from the American Society of Clinical Oncology (ASCO).
Trending:
ASCO: Checkpoint inhibitor drugs top cancer advances in 2015
The rise of immunotherapy topped all other advances in oncology during 2015, according to an annual research report from the American Society of Clinical Oncology (ASCO).